DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Lalwani GA, Rosenfeld PJ, Fung AE. et al.
A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.
Am J Ophthalmol 2009;
148: 43-58.e1
We do not assume any responsibility for the contents of the web pages of other providers.